How serotonin circuits in the brainstem and cerebellum may cause some SIDS deaths
SIDS, failed autoresuscitation, and a novel serotonergic brainstem-cerebellar circuit
Researchers are looking at whether low serotonin signaling in a specific brainstem–cerebellum circuit causes some sudden infant deaths so we can better protect at‑risk infants.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-11330278 on NIH RePORTER |
What this research studies
This project looks at a brain circuit that helps babies recover heart rate and blood pressure when oxygen falls. The team will examine serotonin (5‑HT) and 5‑HT2A receptor changes in key sites like the nucleus of the solitary tract, medial accessory olive, Purkinje cells, and fastigial nucleus using human tissue and animal models of intermittent low oxygen. They will test how damage to these parts of the circuit affects the autoresuscitation response that normally saves infants from severe hypoxia. The work aims to explain why some infants fail to recover so families and clinicians can target prevention or detection strategies.
Who could benefit from this research
Good fit: Ideal participants would be families of infants who have died from SIDS willing to donate tissue or data, or infants with prenatal or postnatal intermittent hypoxia risk factors who can be followed for observational data.
Not a fit: Healthy children, adults, or families without SIDS risk factors are unlikely to receive direct benefit from this project.
Why it matters
Potential benefit: If successful, this work could reveal biomarkers or treatment targets that help identify or prevent infants at high risk for SIDS.
How similar studies have performed: Previous studies have found reduced serotonin and 5‑HT2A receptors in SIDS brains, but applying those findings to this specific brainstem‑cerebellar circuit and failed autoresuscitation is a newer, mechanistic step.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Cummings, Kevin James — University of Missouri-Columbia
- Study coordinator: Cummings, Kevin James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.